Our results has provided the first demonstration that CVB-D could effectively ameliorates cardiac dysfunction and increases survival in rats with DCM, and was associated with the activation of Nrf2 and its associated signalling targets. The gene discussed is NFE2L2; the disease is familial dilated cardiomyopathy.